Hariman Laboratories Pvt Ltd
About Hariman Laboratories Pvt Ltd
Data last updated:
Hariman Laboratories Pvt Ltd is a private limited company based in Mumbai, Maharashtra, India. It operates in the real estate financing segment of the financial services sector. It was incorporated on 16 August 1989 and has been in existence for over 37 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U70100MH1989PTC053052. Its GSTIN is 27AAACH7280E1ZN (Maharashtra).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4 Cr. It is led by directors including Nihchal Israni (Whole-Time Director) and Mahinder Naraindas Punwani.
Its last annual general meeting (AGM) was held on 07 May 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Peninsula Chambersganpatrao Kadam Marg Lower Parel, Mumbai, Maharashtra, India – 400013.
As per the financials filed for FY 2026, the company reported a revenue of ₹69.45 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹60.92 Cr (net margin 87.7%) and EBITDA of ₹66.04 Cr (EBITDA margin 95.1%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 14% over five years.
The company has 3 deals on record (3 secondary share transfers); the latest was in February 2014. Its 10 peer companies in the BFSI industry (Real Estate Leasing) are compared by revenue, 5 larger and 5 smaller; the largest is Krishna Developers Private Limited with revenue of ₹72.22 Cr.
The current compliance status is marked as compliant by the Registrar of Companies.
CIN History of Hariman Laboratories Pvt Ltd
Hariman Laboratories has one previous CIN (Corporate Identification Number): U85190MH1989PTC053052. The current CIN is U70100MH1989PTC053052, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U70100MH1989PTC053052 | Current |
| U85190MH1989PTC053052 | Previous |
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPeninsula Chambersganpatrao Kadam Marg Lower Parel, Mumbai, Maharashtra, India – 400013
- IndustryFinancial Services, Real Estate Financing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Hariman Laboratories Pvt Ltd
The main business activities of Hariman Laboratories are real estate and financial and insurance service. In detail, this covers real estate activities with own or leased property and other financial activities. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| L | Real Estate | L1 | Real estate activities with own or leased property | Locked |
| K | Financial and insurance Service | K8 | Other financial activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Hariman Laboratories Pvt Ltd FY 2025 filings available
Hariman Laboratories Pvt Ltd reported revenue of ₹69.45 Cr (down 1% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR) of Hariman Laboratories Pvt Ltd
Revenue fell 1% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 14%. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Hariman Laboratories Pvt Ltd
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹66.04 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹60.92 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Hariman Laboratories Pvt Ltd
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 95.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 87.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Hariman Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Hariman Laboratories Pvt Ltd
Hariman Laboratories has 4 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mahinder Naraindas Punwani Also directs: Nihchal Israni Foundation | Director | 17 Mar 2021 | 5 Years 7 Months | Current |
| Suresh Mahalingam | Director | 10 Oct 2017 | 9 Years 0 Months | Current |
| Manoj Nihchal Israni Also directs: Blue Cross Laboratories Private Limited, Nihchal Israni Foundation, Vesper LLP and 2 more | Director | 21 Jun 2018 | 8 Years 4 Months | Current |
| Nihchal Israni Also directs: Blue Cross Laboratories Private Limited, Nihchal Israni Foundation | Whole-Time Director | 01 Jul 2006 | 20 Years 3 Months | Current |
Peer Comparison of Hariman Laboratories Pvt Ltd
Hariman Laboratories Pvt Ltd is compared with the companies closest to it by revenue in the BFSI industry (Real Estate Leasing). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Krishna Developers Private Limited | ₹72.22 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Mumbai, Maharashtra, India |
| Universal Infra Private Limited | ₹72.21 Cr (FY 2025) | •••• | •••• | 43.0% | •••• | Guruhrsahai, Punjab, India |
| TDM Fabrics Private Limited | ₹71.93 Cr (FY 2025) | •••• | •••• | -16.0% | •••• | Delhi, India |
| Jaymala Infrastructure Private Limited | ₹71.69 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Mumbai, Maharashtra, India |
| Walkwater Properties Private Limited | ₹70.18 Cr (FY 2023) | •••• | •••• | 122.0% | •••• | Mumbai, Maharashtra, India |
| Hariman Laboratories Pvt Ltd this company | ₹69.45 Cr (FY 2026) | •••• | •••• | -1.0% | •••• | Mumbai, Maharashtra, India |
| Aayush Shreyesh Properties Private Limited | ₹68.95 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Ranchi, Jharkhand, India |
| Subh Properties Private Limited | ₹68.73 Cr (FY 2025) | •••• | •••• | 21.0% | •••• | Kolkata, West Bengal, India |
| Iti Holdings and Investment Private Limited | ₹68.54 Cr (FY 2025) | •••• | •••• | -81.0% | •••• | Chennai, Tamil Nadu, India |
| Avmm Associates Private Limited | ₹68.29 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Tuticorin, Tamil Nadu, India |
| Golden Shelters Private Limited | ₹68.22 Cr (FY 2025) | •••• | •••• | 68.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Hariman Laboratories by revenue in the BFSI industry (Real Estate Leasing), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Hariman Laboratories Pvt Ltd
Hariman Laboratories Pvt Ltd is audited by ASKA & CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ASKA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Hariman Laboratories Pvt Ltd
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Hariman Laboratories Pvt Ltd
Hariman Laboratories Pvt Ltd does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Hariman Laboratories Pvt Ltd
Hariman Laboratories Pvt Ltd has 3 deals on record (3 secondary share transfers); the latest was in February 2014.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2014 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: N. H. Israni (HUF) |
| Mar 2010 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2007 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
Full deal history
All 3 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance at Hariman Laboratories Pvt Ltd
Employment history and EPFO contributions of people linked to Hariman Laboratories.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Hariman Laboratories Pvt Ltd
Hariman Laboratories Pvt Ltd has 13 board changes on record since 2006: 4 appointments and 9 cessations. The latest: Rajendra Yeshwant Padhye ceased to be Director on 20 Jun 2022.
4 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Hariman Laboratories Pvt Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Hariman Laboratories Pvt Ltd
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Hariman Laboratories Pvt Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Hariman Laboratories Pvt Ltd
Hariman Laboratories has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACH7280E1ZN | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Hariman Laboratories Pvt Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hariman Laboratories Pvt Ltd
Hariman Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in real estate financing, within the financial services industry. It was incorporated on 16 August 1989 (37+ years old) and is registered under CIN U70100MH1989PTC053052.
Hariman Laboratories reported revenue of ₹69.45 Cr for FY 2026 (down 1% YoY).
Hariman Laboratories has 4 current directors:
- Nihchal Israni - Whole-Time Director
- Mahinder Naraindas Punwani - Director
- Suresh Mahalingam - Director
- Manoj Nihchal Israni - Director
Hariman Laboratories reported a net profit of ₹60.92 Cr (net margin 87.7%) and EBITDA of ₹66.04 Cr (EBITDA margin 95.1%) for FY 2026, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Hariman Laboratories is 12% over three years and 14% over five years. In the latest year (FY 2026) revenue fell 1%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Hariman Laboratories is 27AAACH7280E1ZN, registered in Maharashtra.
The CIN (Corporate Identification Number) of Hariman Laboratories is U70100MH1989PTC053052. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hariman Laboratories was incorporated on 16 August 1989, making it 37+ years old. It is registered with the Registrar of Companies, Mumbai.
Hariman Laboratories has 3 deals on record (3 secondary share transfers); the latest was in February 2014.
The peers of Hariman Laboratories by revenue are Krishna Developers Private Limited, Universal Infra Private Limited, TDM Fabrics Private Limited, Jaymala Infrastructure Private Limited, Walkwater Properties Private Limited and 5 more, all in the BFSI industry (Real Estate Leasing).
Rajendra Yeshwant Padhye ceased to be Director on 20 Jun 2022. Mahinder Naraindas Punwani ceased to be Additional Director on 28 Jun 2021. Bhalchandra Barve Govind ceased to be Director on 17 Mar 2021. Hariman Laboratories has 13 board changes on record in total.